-
Featured
Identifying Risk Factors for Type 2 Myocardial Infarction
In one of the first large systematic surveys of the frequency and implications of supply/demand-related Type 2 Myocardial Infarction, a suite of risk factors has been identified to help ensure patients receive proper care.
-
Featured
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
Damage to the mitral valve after heart attack leads to HF and death. Treatment with hypertension drug may reduce mitral valve scaring and stiffening.
-
Featured
DNA is not Destiny When it Comes to Heart Attack Risk
A study led by Sekar Kathiresan, MD, of Mass General, has found that having a favorable lifestyle can help those with a high genetic risk of having a heart attack reduce their risk by over 50%.
-
Better Prognostic Risk Scoring Needed for Patients with Type 2 Myocardial Infarction
In this first study of its kind, the GRACE, TIMI and TARRACO scores were at best only modestly predictive of adverse outcomes in patients with type 2 myocardial infarction.
-
Cardiovascular Safety of Tramadol Not Assured for Osteoarthritis Patients
In a large population-based study of patients with osteoarthritis, the risk of myocardial infarction with tramadol was higher or comparable to that with NSAIDs and comparable to that with codeine.
-
Review: Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays
Myocardial injury carries a worse prognosis than MI and warrants a thorough evaluation for its underlying precipitant.
Myocardial Infarction contributors
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Review: Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays
-
Pradeep Natarajan, MD, MMSc
Director, Preventive Cardiology, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Preventing and Managing CVD in the COVID-19 Era
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
